S. Golombowski

Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity

J. Growdon, R. Tanzi, R. Nitsch, 1998, European Neurology.

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients

C. Hock, S. Rose-John, K. Heese, 1997, Neuroscience Letters.

Increased blood mercury levels in patients with Alzheimer's disease

J. Growdon, R. Nitsch, C. Hock, 1998, Journal of Neural Transmission.

ELISA-Quantitation of Phosphorylated Tau Protein in the Alzheimer’s Disease Brain

C. Hock, K. Kräuchi, F. Müller-Spahn, 1999, European Neurology.

Histological Markers in Nasal Mucosa of Patients with Alzheimer’s Disease

C. Hock, E. Mandelkow, O. Peschel, 1998, European Neurology.

Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairment

C. Hock, W. Naser, F. Müller-Spahn, 1995, Annals of neurology.

Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease

C. Hock, F. Müller-Spahn, H. Romig, 1997, Neuroscience Letters.